preclinical white papers and articles

  1. The Future Of Clinical Trials: 2025 Outlook 1/27/2025

    Looking ahead to 2025, clinical trials will evolve with new technologies, regulatory shifts, and emerging therapies. Explore key trends shaping the future of the industry.

  2. Fit-For-Purpose Biomarker Development 1/17/2025

    Here, we highlight the essential framework of a “fit-for-purpose” biomarker development strategy, emphasizing strategic and transactional engagements with clinical research organizations.

  3. Biomarkers In Oncology Studies 1/17/2025

    Here we provide an overview of oncology biomarker development and strategic considerations.

  4. Breaking Barriers In Drug Development: Time, Trust And Putting Patients First 1/16/2025

    Unpack systemic challenges in drug development that inflate costs and delay life-saving treatments. Learn about streamlining processes, fostering patient trust, and reallocating resources efficiently.

  5. Epidermolysis Bullosa: Future Perspectives In Drug Development 1/14/2025

    Recent breakthroughs are signaling a promising shift in the landscape of Epidermolysis bullosa (EB) care from focusing on pain management to a growing commitment to curative strategies.

  6. Gene Therapy In Neurology: The Case For Optimism 1/14/2025

    Advancements in genetic therapy are revolutionizing the treatment of neurological diseases, with promising results from preclinical studies leading to clinical trials focused on safety and efficacy.

  7. Overview Of Parkinson's Disease: Global Clinical Trials Landscape 12/27/2024

    Parkinson's disease affects over 8.5 million globally. Explore how advances in gene therapy, Deep Brain Stimulation, and innovative drugs are transforming treatment and improving patient outcomes.

  8. Overview Of COVID-19: Global Clinical Trial Landscape 12/27/2024

    Explore how COVID-19 has led to significant global morbidity and mortality. Advances in vaccines, therapies, and clinical trials are enhancing disease management and outcomes.

  9. Antibody-Drug Conjugates In Oncology: Revolutionizing Cancer Treatment 11/20/2024

    ADCs are reshaping cancer treatment by combining targeted delivery with potent cell-killing agents. Learn how these therapies offer new hope for patients and exciting opportunities for drug developers.

  10. Managing The Complexities Of Glucagon-Like Peptide-1 Receptor Agonist Drug Development 11/20/2024

    Dive into the dynamic world of GLP-1 receptor agonists, where we explore the current landscape, the challenges ahead and the complexities of early-phase drug development.